Impact of active smoking on outcomes in HPV+ oropharyngeal cancer.
Roy XiaoYvonne PhamMatthew C WardNarcissa HoustonChandana A ReddyNikhil P JoshiJohn F GreskovichNeil M WoodyDeborah J ChuteEric D LamarreBrandon L PrendesRobert R LorenzJoseph ScharpfBrian B BurkeyJessica L GeigerDavid J AdelsteinShlomo A KoyfmanPublished in: Head & neck (2019)
For patients with HPV(+) OPSCC, active smoking at diagnosis is the most powerful covariate capturing smoking history to predict OS and PFS.